Next-gen insulin pump from Insulet receives 510(k) clearance

12/16/2012 | American City Business Journals

The FDA has cleared Insulet to market a next-generation version of its OmniPod system, which is used to deliver insulin in diabetes patients. The company said the newly cleared device, which is one-quarter lighter and one-third smaller than the original version launched in 2005, is expected to arrive in the U.S. in March.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT